{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:05Z","timestamp":1786984145405,"version":"build-2736575974"},"reference-count":266,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Shanghai Jiao Tong University School of Medicine","award":["BXJ201736"],"award-info":[{"award-number":["BXJ201736"]}]},{"name":"Shanghai Key Discipline of Medical Imaging","award":["2017ZZ02005"],"award-info":[{"award-number":["2017ZZ02005"]}]},{"name":"University of Wisconsin - Madison"},{"name":"National Natural Science Foundation of China","award":["81630049"],"award-info":[{"award-number":["81630049"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA014520"],"award-info":[{"award-number":["P30CA014520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA009206"],"award-info":[{"award-number":["T32CA009206"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM008505"],"award-info":[{"award-number":["T32GM008505"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["125246-RSG-13-099-01-CCE"],"award-info":[{"award-number":["125246-RSG-13-099-01-CCE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.addr.2018.06.022","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T21:14:49Z","timestamp":1530566089000},"page":"16-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Molecular imaging of \u03b2-cells: diabetes and beyond"],"prefix":"10.1016","volume":"139","author":[{"given":"Weijun","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Ehlerding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Yong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2018.06.022_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","article-title":"Global healthcare expenditure on diabetes for 2010 and 2030","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.addr.2018.06.022_bb0010","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1001\/jama.2014.3201","article-title":"Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009","volume":"311","author":"Dabelea","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2018.06.022_bb0015","series-title":"Global Report on Diabetes","author":"W.H. Organization","year":"2016"},{"key":"10.1016\/j.addr.2018.06.022_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.addr.2018.06.022_bb0025","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical Care in diabetes-2018","volume":"41","author":"A. American Diabetes","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.addr.2018.06.022_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","article-title":"Type 1 diabetes: etiology, immunology, and therapeutic strategies","volume":"91","author":"van Belle","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.addr.2018.06.022_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/dmr.5610050804","article-title":"Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes","volume":"5","author":"Caro","year":"1989","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.addr.2018.06.022_bb0040","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0584","article-title":"Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms","volume":"220","author":"Guo","year":"2014","journal-title":"J. Endocrinol."},{"issue":"Suppl. 4","key":"10.1016\/j.addr.2018.06.022_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-1326.2008.00939.x","article-title":"Relationship between beta-cell mass and diabetes onset","volume":"10","author":"Matveyenko","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"\u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2337\/diabetes.51.2.413","article-title":"Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to \u03b2-cell survival during chronic hyperglycemia","volume":"51","author":"Laybutt","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0060","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five stages of evolving beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0065","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/db07-0742","article-title":"Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient?","volume":"56","author":"Robertson","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0070","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s00125-016-3959-7","article-title":"In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use","volume":"59","author":"Eriksson","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0075","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/er.2011-1041","article-title":"Imaging of beta-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus","volume":"33","author":"Di Gialleonardo","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.addr.2018.06.022_bb0080","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00125-012-2491-7","article-title":"Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis","volume":"55","author":"Andralojc","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11307-013-0620-4","article-title":"Beta-cell imaging: call for evidence-based and scientific approach","volume":"15","author":"Blomberg","year":"2013","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/dom.12544","article-title":"Pancreatic beta-cell imaging in humans: fiction or option?","volume":"18","author":"Laurent","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.TP.0000149501.50870.9D","article-title":"Positron-emission tomography imaging of early events after transplantation of islets of Langerhans","volume":"79","author":"Toso","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2018.06.022_bb0100","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1600-6143.2009.02844.x","article-title":"Positron emission tomography in clinical islet transplantation","volume":"9","author":"Eriksson","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2018.06.022_bb0105","first-page":"525","article-title":"Fate of 2-deoxy-2-[18F]fluoro-d-glucose in control and diabetic rats","volume":"5","author":"Malaisse","year":"2000","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0110","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.addr.2010.09.006","article-title":"Radionuclide probes for molecular imaging of pancreatic beta-cells","volume":"62","author":"Wu","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Suppl. 3","key":"10.1016\/j.addr.2018.06.022_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1463-1326.2012.01651.x","article-title":"Neurofunctional imaging of beta-cell dynamics","volume":"14","author":"Harris","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/isl.20857","article-title":"Pancreatic magnetic resonance imaging after manganese injection distinguishes type 2 diabetic and normoglycemic patients","volume":"4","author":"Botsikas","year":"2012","journal-title":"Islets"},{"key":"10.1016\/j.addr.2018.06.022_bb0125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2967\/jnumed.108.054866","article-title":"11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls","volume":"50","author":"Goland","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0130","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2967\/jnumed.111.100545","article-title":"In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET","volume":"53","author":"Normandin","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0135","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2967\/jnumed.109.065664","article-title":"18F-FDOPA: a multiple-target molecule","volume":"50","author":"Minn","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2967\/jnumed.115.167445","article-title":"Glucagon-like peptide-1 receptor PET\/CT with 68Ga-NOTA-exendin-4 for detecting localized insulinoma: a prospective cohort study","volume":"57","author":"Luo","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0145","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/nbm.1542","article-title":"Functional MRI characterization of isolated human islet activation","volume":"23","author":"Leoni","year":"2010","journal-title":"NMR Biomed."},{"key":"10.1016\/j.addr.2018.06.022_bb0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3727\/000000006783982151","article-title":"Functional MR microimaging of pancreatic beta-cell activation","volume":"15","author":"Gimi","year":"2006","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2018.06.022_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12194-010-0098-6","article-title":"Measurement of manganese content in various organs in rats with or without glucose stimulation","volume":"4","author":"Nagata","year":"2011","journal-title":"Radiol. Phys. Technol."},{"key":"10.1016\/j.addr.2018.06.022_bb0160","doi-asserted-by":"crossref","first-page":"E573","DOI":"10.1152\/ajpendo.90336.2008","article-title":"Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging","volume":"296","author":"Antkowiak","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0165","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2337\/db11-0726","article-title":"High-resolution magnetic resonance imaging quantitatively detects individual pancreatic islets","volume":"60","author":"Lamprianou","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/db12-0153","article-title":"Manganese-enhanced magnetic resonance imaging detects declining pancreatic beta-cell mass in a cyclophosphamide-accelerated mouse model of type 1 diabetes","volume":"62","author":"Antkowiak","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0175","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.2337\/db14-0864","article-title":"Manganese-mediated MRI signals correlate with functional beta-cell mass during diabetes progression","volume":"64","author":"Meyer","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0180","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/db09-1177","article-title":"Unique arrangement of alpha- and beta-cells in human islets of Langerhans","volume":"59","author":"Bosco","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1306.018","article-title":"Manganese-induced parkinsonism and Parkinson's disease","volume":"1012","author":"Olanow","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2018.06.022_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-2952(03)00145-X","article-title":"Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese","volume":"66","author":"Roth","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2018.06.022_bb0195","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/mrm.20368","article-title":"Manganese-enhanced magnetic resonance imaging of mouse brain after systemic administration of MnCl2: dose-dependent and temporal evolution of T1 contrast","volume":"53","author":"Lee","year":"2005","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0200","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00259-016-3592-1","article-title":"Targets and probes for non-invasive imaging of beta-cells","volume":"44","author":"Jodal","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.addr.2016.08.001","article-title":"Positron emission tomography and nanotechnology: a dynamic duo for cancer theranostics","volume":"113","author":"Goel","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.06.022_bb0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2967\/jnumed.107.043331","article-title":"Multimodality molecular imaging with combined optical and SPECT\/PET modalities","volume":"49","author":"Culver","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2967\/jnumed.115.166199","article-title":"Harnessing the power of molecular imaging for precision medicine","volume":"57","author":"Ehlerding","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0220","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41598-017-03202-0","article-title":"Preparation and in vivo characterization of 51MnCl2 as PET tracer of Ca2+ channel-mediated transport","volume":"7","author":"Graves","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.06.022_bb0225","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2337\/db16-1285","article-title":"Radiomanganese PET detects changes in functional beta-cell mass in mouse models of diabetes","volume":"66","author":"Hernandez","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0230","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1210\/en.2004-0691","article-title":"Identification of tissue-restricted transcripts in human islets","volume":"145","author":"Maffei","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.addr.2018.06.022_bb0235","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/002215540305100806","article-title":"Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors","volume":"51","author":"Anlauf","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.addr.2018.06.022_bb0240","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1096\/fj.00-0202rev","article-title":"Chemical neuroanatomy of the vesicular amine transporters","volume":"14","author":"Weihe","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2018.06.022_bb0245","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/0969-8043(93)90103-H","article-title":"Synthesis of a [11C]methoxy derivative of alpha-dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter","volume":"44","author":"DaSilva","year":"1993","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.addr.2018.06.022_bb0250","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0969-8051(94)90003-5","article-title":"Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter","volume":"21","author":"DaSilva","year":"1994","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0255","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/00004647-199611000-00025","article-title":"Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter","volume":"16","author":"Koeppe","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0260","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.nucmedbio.2006.07.002","article-title":"Visualizing pancreatic beta-cell mass with [11C]DTBZ","volume":"33","author":"Simpson","year":"2006","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0265","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI27645","article-title":"Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model","volume":"116","author":"Souza","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2018.06.022_bb0270","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00109-007-0242-x","article-title":"VMAT2 gene expression and function as it applies to imaging beta-cell mass","volume":"86","author":"Harris","year":"2008","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"Suppl. 4","key":"10.1016\/j.addr.2018.06.022_bb0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1463-1326.2008.00943.x","article-title":"VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease","volume":"10","author":"Freeby","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0280","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.surg.2009.08.005","article-title":"The utility of [(11)C] dihydrotetrabenazine positron emission tomography scanning in assessing beta-cell performance after sleeve gastrectomy and duodenal-jejunal bypass","volume":"147","author":"Inabnet","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.addr.2018.06.022_bb0285","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.nucmedbio.2008.08.004","article-title":"In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine","volume":"35","author":"Kung","year":"2008","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0290","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.108.051680","article-title":"In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus","volume":"49","author":"Kung","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0295","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11307-010-0406-x","article-title":"Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes","volume":"13","author":"Singhal","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.nucmedbio.2009.12.004","article-title":"In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass","volume":"37","author":"Eriksson","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0305","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nucmedbio.2010.01.002","article-title":"Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats","volume":"37","author":"Tsao","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0310","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2967\/jnumed.110.078196","article-title":"Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent","volume":"51","author":"Lin","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0315","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11307-015-0888-7","article-title":"Cross-sectional and test-retest characterization of PET with [(18)F]FP-(+)-DTBZ for beta cell mass estimates in diabetes","volume":"18","author":"Freeby","year":"2016","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0320","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2967\/jnumed.109.074492","article-title":"Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas","volume":"51","author":"Fagerholm","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0325","doi-asserted-by":"crossref","first-page":"20719","DOI":"10.1073\/pnas.1109480108","article-title":"Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands","volume":"108","author":"Virostko","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.06.022_bb0330","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2967\/jnumed.110.085530","article-title":"Beta-cell imaging: opportunities and limitations","volume":"52","author":"Kwee","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0335","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2967\/jnumed.109.068999","article-title":"Imaging of beta-cell mass and function","volume":"51","author":"Ichise","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0340","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.nucmedbio.2016.08.018","article-title":"Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of 18F-FP-DTBZ in baboons","volume":"43","author":"Naganawa","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0345","first-page":"1","article-title":"Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of [(18)F]FP-DTBZ in healthy subjects and patients with type 1 diabetes","author":"Naganawa","year":"2018","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0350","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s005920170012","article-title":"Pancreatic volume in type 1 and type 2 diabetes mellitus","volume":"38","author":"Goda","year":"2001","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.addr.2018.06.022_bb0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1464-5491.2007.02027.x","article-title":"Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes","volume":"24","author":"Williams","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0360","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00259-002-0924-0","article-title":"Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET","volume":"29","author":"Hickeson","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0365","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00259-003-1330-y","article-title":"Positron flight in human tissues and its influence on PET image spatial resolution","volume":"31","author":"Sanchez-Crespo","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0370","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.semnuclmed.2007.01.005","article-title":"Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states","volume":"37","author":"Basu","year":"2007","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0375","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10735-008-9195-9","article-title":"Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas","volume":"39","author":"Saisho","year":"2008","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.addr.2018.06.022_bb0380","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.nucmedbio.2012.09.003","article-title":"PET quantification of pancreatic VMAT 2 binding using (+) and (\u2212) enantiomers of [(1)(8)F]FP-DTBZ in baboons","volume":"40","author":"Harris","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0385","doi-asserted-by":"crossref","first-page":"29122","DOI":"10.1074\/jbc.274.41.29122","article-title":"Membrane topology of the amino-terminal region of the sulfonylurea receptor","volume":"274","author":"Raab-Graham","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0390","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1152\/physrev.1998.78.1.227","article-title":"Toward understanding the assembly and structure of KATP channels","volume":"78","author":"Aguilar-Bryan","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.addr.2018.06.022_bb0395","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1385\/ENDO:12:3:329","article-title":"Uptake of tritiated glibenclamide by endocrine and exocrine pancreas","volume":"12","author":"Ladriere","year":"2000","journal-title":"Endocrine"},{"key":"10.1016\/j.addr.2018.06.022_bb0400","first-page":"2211","article-title":"Glucose-sensing mechanisms in pancreatic beta-cells","volume":"360","author":"MacDonald","year":"2005","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.addr.2018.06.022_bb0405","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00125-007-0731-z","article-title":"Morphological localisation of sulfonylurea receptor 1 in endocrine cells of human, mouse and rat pancreas","volume":"50","author":"Guiot","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0410","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00454887","article-title":"Internalization of 3H-glibenclamide in pancreatic islet cells","volume":"29","author":"Carpentier","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0415","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jlcr.438","article-title":"Synthesis of fluorine-18 labeled sulfonureas as \u03b2-cell imaging agents","volume":"44","author":"Shiue","year":"2001","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.addr.2018.06.022_bb0420","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jlcr.599","article-title":"Radiosynthesis of 1-(4-(2-[18F] fluoroethoxy) benzenesulfonyl)-3-butyl urea: a potential \u03b2-cell imaging agent","volume":"45","author":"Schirrmacher","year":"2002","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.addr.2018.06.022_bb0425","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-2005-865711","article-title":"In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans","volume":"113","author":"Schneider","year":"2005","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0430","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1208\/s12248-013-9514-2","article-title":"Effects of selected OATP and\/or ABC transporter inhibitors on the brain and whole-body distribution of glyburide","volume":"15","author":"Tournier","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2018.06.022_bb0435","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.regpep.2006.11.004","article-title":"Synthesis and evaluation of a glibenclamide glucose-conjugate: a potential new lead compound for substituted glibenclamide derivatives as islet imaging agents","volume":"139","author":"Schneider","year":"2007","journal-title":"Regul. Pept."},{"key":"10.1016\/j.addr.2018.06.022_bb0440","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/11207600-000000000-00000","article-title":"Repaglinide: a review of its use in type 2 diabetes mellitus","volume":"72","author":"Scott","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2018.06.022_bb0445","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.nucmedbio.2004.01.007","volume":"31","author":"Wangler","year":"2004","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0450","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.bmcl.2004.07.059","article-title":"Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-be nzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent","volume":"14","author":"Wangler","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.06.022_bb0455","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrendo.2009.103","article-title":"Noninvasive imaging of pancreatic beta cells","volume":"5","author":"Malaisse","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.addr.2018.06.022_bb0460","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1016\/j.bmc.2014.04.059","article-title":"Synthesis and evaluation of 18F-labeled mitiglinide derivatives as positron emission tomography tracers for beta-cell imaging","volume":"22","author":"Kimura","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0465","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nucmedbio.2003.12.003","article-title":"Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents","volume":"31","author":"Schmitz","year":"2004","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0470","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1463-1326.2012.01663.x","article-title":"GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence","volume":"15","author":"Meloni","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0475","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.addr.2018.06.022_bb0480","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0485","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.toxicon.2010.12.016","article-title":"The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent","volume":"59","author":"Furman","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.addr.2018.06.022_bb0490","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1074\/jbc.M708740200","article-title":"Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain","volume":"283","author":"Runge","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0495","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/14656566.7.8.1055","article-title":"Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus","volume":"7","author":"Briones","year":"2006","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.addr.2018.06.022_bb0500","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0505","doi-asserted-by":"crossref","first-page":"12815","DOI":"10.1073\/pnas.1109859108","article-title":"Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog","volume":"108","author":"Reiner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.06.022_bb0510","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/bc4005014","article-title":"Fluorescent exendin-4 derivatives for pancreatic beta-cell analysis","volume":"25","author":"Clardy","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0515","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2337\/db14-1212","article-title":"(111)In-exendin uptake in the pancreas correlates with the beta-cell mass and not with the alpha-cell mass","volume":"64","author":"Brom","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0520","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11307-013-0700-5","article-title":"64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats","volume":"16","author":"Mikkola","year":"2014","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0525","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2967\/jnumed.112.114066","article-title":"In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4","volume":"54","author":"Selvaraju","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0530","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2337\/db13-1543","article-title":"GLP-1R-targeting magnetic nanoparticles for pancreatic islet imaging","volume":"63","author":"Wang","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0535","first-page":"2025","article-title":"[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting","volume":"47","author":"Wild","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0540","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s00259-014-2745-3","article-title":"Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs","volume":"41","author":"Nalin","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0545","first-page":"147","article-title":"Exendin peptides","volume":"59","author":"Eng","year":"1992","journal-title":"Mt Sinai J. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0550","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.regpep.2006.07.005","article-title":"A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents","volume":"137","author":"Gotthardt","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.addr.2018.06.022_bb0555","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2009.09.014","article-title":"GLP-1 receptor antagonist as a potential probe for pancreatic beta-cell imaging","volume":"389","author":"Mukai","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2018.06.022_bb0560","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1016\/j.bmc.2017.09.005","article-title":"Synthesis and biological evaluation of an (111)In-labeled exendin-4 derivative as a single-photon emission computed tomography probe for imaging pancreatic beta-cells","volume":"25","author":"Kimura","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0565","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00125-014-3166-3","article-title":"Non-invasive quantification of the beta cell mass by SPECT with (1)(1)(1)In-labelled exendin","volume":"57","author":"Brom","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0570","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40658-016-0165-0","article-title":"A 3D-printed anatomical pancreas and kidney phantom for optimizing SPECT\/CT reconstruction settings in beta cell imaging using 111In-exendin","volume":"3","author":"Woliner-van der Weg","year":"2016","journal-title":"EJNMMI Phys."},{"key":"10.1016\/j.addr.2018.06.022_bb0575","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nucmedbio.2011.07.011","article-title":"Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic beta-cell mass","volume":"39","author":"Wang","year":"2012","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0580","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bmc.2017.12.007","article-title":"Evaluation of (18)F-labeled exendin(9-39) derivatives targeting glucagon-like peptide-1 receptor for pancreatic beta-cell imaging","volume":"26","author":"Kimura","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0585","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2016.01.184","article-title":"Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4","volume":"471","author":"Mi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2018.06.022_bb0590","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11307-011-0481-7","article-title":"Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist","volume":"14","author":"Connolly","year":"2012","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0595","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11307-016-0936-y","article-title":"Strain differences determine the suitability of animal models for noninvasive in vivo beta cell mass determination with radiolabeled exendin","volume":"18","author":"Willekens","year":"2016","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0600","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1006\/cbir.2002.0952","article-title":"Specific monoclonal antibodies against the surface of rat islet beta cells","volume":"26","author":"Konidaris","year":"2002","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.addr.2018.06.022_bb0605","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/BF00400250","article-title":"Monoclonal antibody-mediated cytotoxicity against rat beta cells detected in vitro does not cause beta-cell destruction in vivo","volume":"35","author":"Ziegler","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0610","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1900\/RDS.2008.5.6","article-title":"Imaging the Beta-cell mass: why and how","volume":"5","author":"Saudek","year":"2008","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.addr.2018.06.022_bb0615","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cbf.903","article-title":"Pancreatic fate of a (125)I-labelled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats","volume":"19","author":"Ladriere","year":"2001","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.addr.2018.06.022_bb0620","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00125-010-1728-6","article-title":"The role of transmembrane protein 27 (TMEM27) in islet physiology and its potential use as a beta cell mass biomarker","volume":"53","author":"Altirriba","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0625","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cmet.2005.11.001","article-title":"Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation","volume":"2","author":"Akpinar","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0630","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00125-012-2605-2","article-title":"Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)","volume":"55","author":"Vats","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0635","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1699-0463.1988.tb05313.x","article-title":"Antigen expression of the pancreatic beta-cells is dependent on their functional state, as shown by a specific, BB rat monoclonal autoantibody IC2","volume":"96","author":"Buschard","year":"1988","journal-title":"APMIS"},{"key":"10.1016\/j.addr.2018.06.022_bb0640","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF00452071","article-title":"Production and characterization of a monoclonal islet cell surface autoantibody from the BB rat","volume":"29","author":"Brogren","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2018.06.022_bb0645","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/diabetes.50.10.2231","article-title":"Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes","volume":"50","author":"Moore","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0650","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2337\/db09-0658","article-title":"Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo","volume":"58","author":"Ueberberg","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0655","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00592-017-1059-x","article-title":"Pancreatic imaging using an antibody fragment targeting the zinc transporter type 8: a direct comparison with radio-iodinated Exendin-4","volume":"55","author":"Eriksson","year":"2018","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.addr.2018.06.022_bb0660","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2005-865716","article-title":"Quantitative evaluation of a monoclonal antibody and its fragment as potential markers for pancreatic beta cell mass","volume":"113","author":"Hampe","year":"2005","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0665","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2337\/diabetes.53.9.2330","article-title":"Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules","volume":"53","author":"Chimienti","year":"2004","journal-title":"Diabetes"},{"issue":"38","key":"10.1016\/j.addr.2018.06.022_bb0670","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.1073\/pnas.1711169114","article-title":"Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform","volume":"114","author":"Wan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.06.022_bb0675","doi-asserted-by":"crossref","first-page":"25778","DOI":"10.1074\/jbc.M111.246082","article-title":"Glucose regulates free cytosolic Zn(2)(+) concentration, Slc39 (ZiP), and metallothionein gene expression in primary pancreatic islet beta-cells","volume":"286","author":"Bellomo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0680","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2337\/db09-0551","article-title":"Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants","volume":"58","author":"Nicolson","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0685","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nmeth.1368","article-title":"Genetically encoded FRET sensors to monitor intracellular Zn2+ homeostasis","volume":"6","author":"Vinkenborg","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.addr.2018.06.022_bb0690","first-page":"619","article-title":"Zinc ions in the endocrine and exocrine pancreas of zinc deficient rats","volume":"21","author":"Sondergaard","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.addr.2018.06.022_bb0695","doi-asserted-by":"crossref","first-page":"11387","DOI":"10.1021\/ja901875v","article-title":"A new gadolinium-based MRI zinc sensor","volume":"131","author":"Esqueda","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.06.022_bb0700","doi-asserted-by":"crossref","first-page":"18400","DOI":"10.1073\/pnas.1109649108","article-title":"Noninvasive MRI of beta-cell function using a Zn2+-responsive contrast agent","volume":"108","author":"Lubag","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.06.022_bb0705","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1002\/chem.201406008","article-title":"Dual-modal magnetic resonance\/fluorescent zinc probes for pancreatic beta-cell mass imaging","volume":"21","author":"Stasiuk","year":"2015","journal-title":"Chemistry"},{"key":"10.1016\/j.addr.2018.06.022_bb0710","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0715","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.06.022_bb0720","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.bbrc.2005.10.161","article-title":"GPR40 gene expression in human pancreas and insulinoma","volume":"338","author":"Tomita","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2018.06.022_bb0725","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1021\/acschembio.5b00791","article-title":"Synthesis and characterization of a promising novel FFAR1\/GPR40 targeting fluorescent probe for beta-cell imaging","volume":"11","author":"Bertrand","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0730","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jlcr.3412","article-title":"Synthesis of GPR40 targeting 3 H- and 18 F-probes towards selective beta cell imaging","volume":"59","author":"Bertrand","year":"2016","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.addr.2018.06.022_bb0735","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diabetes.48.1.77","article-title":"Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis","volume":"48","author":"Kumar","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0740","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/jsre.1995.1136","article-title":"Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas","volume":"59","author":"Moldovan","year":"1995","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.addr.2018.06.022_bb0745","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.apradiso.2006.01.009","article-title":"Synthesis and evaluation of radioiodinated substituted beta-naphthylalanine as a potential probe for pancreatic beta-cells imaging","volume":"64","author":"Amartey","year":"2006","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.addr.2018.06.022_bb0750","doi-asserted-by":"crossref","first-page":"371716","DOI":"10.1155\/2008\/371716","article-title":"Radioiodinated naphthylalanine derivatives targeting pancreatic beta cells in normal and nonobese diabetic mice","volume":"2008","author":"Amartey","year":"2008","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.addr.2018.06.022_bb0755","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0969-8043(94)90113-9","article-title":"p-[18F]fluorobenzyltrozamicol ([18F]FBT): molecular decomposition-reconstitution approach to vesamicol receptor radioligands for positron emission tomography","volume":"45","author":"Efange","year":"1994","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.addr.2018.06.022_bb0760","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00259-003-1350-7","article-title":"Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol","volume":"31","author":"Clark","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0765","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/dia.2008.0113","article-title":"Enhanced cholinergic response in pancreata of nonhuman primates with impaired glucose tolerance shown on [18F]fluorobenzyltrozamicol positron emission tomography","volume":"11","author":"Clark","year":"2009","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.addr.2018.06.022_bb0770","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/dia.2008.0024","article-title":"Dual radiotracer analysis of cholinergic neuronal changes in prediabetic mouse pancreas","volume":"11","author":"Clark","year":"2009","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.addr.2018.06.022_bb0775","doi-asserted-by":"crossref","first-page":"24576","DOI":"10.1038\/srep24576","article-title":"SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for beta-cell mass assessments","volume":"6","author":"Eter","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.06.022_bb0780","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/bio.676","article-title":"Imaging of light emission from the expression of luciferases in living cells and organisms: a review","volume":"17","author":"Greer","year":"2002","journal-title":"Luminescence"},{"key":"10.1016\/j.addr.2018.06.022_bb0785","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11307-009-0240-1","article-title":"Bioluminescence imaging in mouse models quantifies beta cell mass in the pancreas and after islet transplantation","volume":"12","author":"Virostko","year":"2010","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb0790","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/carcin\/bgq109","article-title":"A bioluminescent mouse model of pancreatic {beta}-cell carcinogenesis","volume":"31","author":"Zumsteg","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.addr.2018.06.022_bb0795","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2310\/7290.2006.00007","article-title":"In vivo monitoring of pancreatic beta-cells in a transgenic mouse model","volume":"5","author":"Smith","year":"2006","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0800","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.10-158121","article-title":"Evaluation of impaired beta-cell function in nonobese-diabetic (NOD) mouse model using bioluminescence imaging","volume":"25","author":"Sever","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2018.06.022_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057784","article-title":"Bioluminescence imaging reveals dynamics of beta cell loss in the non-obese diabetic (NOD) mouse model","volume":"8","author":"Virostko","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.06.022_bb0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106693","article-title":"Non-invasive bioluminescence imaging of beta-cell function in obese-hyperglycemic [ob\/ob] mice","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.06.022_bb0815","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1162\/1535350042973508","article-title":"Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants","volume":"3","author":"Virostko","year":"2004","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0820","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cmmi.1580","article-title":"In vivo visualization of single native pancreatic islets in the mouse","volume":"8","author":"Balla","year":"2013","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0825","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1021\/bc500178d","article-title":"In vivo imaging of GLP-1R with a targeted bimodal PET\/fluorescence imaging agent","volume":"25","author":"Brand","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0830","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/bc100184w","article-title":"Near-infrared fluorescent probe for imaging of pancreatic beta cells","volume":"21","author":"Reiner","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0835","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/open.201200014","article-title":"Efficient 18F-labeling of synthetic exendin-4 analogues for imaging beta cells","volume":"1","author":"Keliher","year":"2012","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.addr.2018.06.022_bb0840","doi-asserted-by":"crossref","first-page":"10385","DOI":"10.1038\/srep10385","article-title":"Combined Optical Coherence and Fluorescence Microscopy to assess dynamics and specificity of pancreatic beta-cell tracers","volume":"5","author":"Berclaz","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.06.022_bb0845","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1021\/acs.bioconjchem.5b00332","article-title":"GLP-1 receptor mediated targeting of a fluorescent Zn(2+) sensor to beta cell surface for imaging insulin\/Zn(2+) release","volume":"26","author":"Li","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.10.006","article-title":"Multivalent glibenclamide to generate islet specific imaging probes","volume":"75","author":"Babic","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.06.022_bb0855","first-page":"151","article-title":"Theranostic magnetic resonance imaging of type 1 diabetes and pancreatic islet transplantation","volume":"2","author":"Wang","year":"2012","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/j.addr.2018.06.022_bb0860","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-0033-1363232","article-title":"Molecular imaging of pancreatic islet transplantation","volume":"122","author":"Liu","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0865","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4329\/wjr.v8.i9.764","article-title":"Imaging pancreatic islet cells by positron emission tomography","volume":"8","author":"Li","year":"2016","journal-title":"World J. Radiol."},{"key":"10.1016\/j.addr.2018.06.022_bb0870","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ymthe.2004.01.008","article-title":"Bioluminescent monitoring of islet graft survival after transplantation","volume":"9","author":"Lu","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2018.06.022_bb0875","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1073\/pnas.0603909103","article-title":"Noninvasive imaging of islet grafts using positron-emission tomography","volume":"103","author":"Lu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.06.022_bb0880","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ymthe.2006.08.007","article-title":"Long-term monitoring of transplanted islets using positron emission tomography","volume":"14","author":"Lu","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2018.06.022_bb0885","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm1458","article-title":"Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival","volume":"12","author":"Kim","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0890","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/db10-0907","article-title":"Multimodality imaging of beta-cells in mouse models of type 1 and 2 diabetes","volume":"60","author":"Yong","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0895","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1021\/bc200132t","article-title":"In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor","volume":"22","author":"Wu","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0900","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJMc1004547","article-title":"GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle","volume":"363","author":"Pattou","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0905","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1039\/c0cc03078c","article-title":"Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes","volume":"46","author":"Li","year":"2010","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.addr.2018.06.022_bb0910","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2310\/7290.2012.00013","article-title":"Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation","volume":"12","author":"Liu","year":"2013","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0915","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2967\/jnumed.112.109694","article-title":"Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets","volume":"54","author":"Wu","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0920","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1038\/s41598-017-07815-3","article-title":"Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3","volume":"7","author":"Eter","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.06.022_bb0925","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00259-011-1928-4","article-title":"Imaging the islet graft by positron emission tomography","volume":"39","author":"Eriksson","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb0930","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0883-2897(88)90088-8","article-title":"Preparation and biodistribution of [125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent","volume":"15","author":"Kung","year":"1988","journal-title":"Int. J. Rad. Appl. Instrum. B"},{"key":"10.1016\/j.addr.2018.06.022_bb0935","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","article-title":"Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts","volume":"6","author":"Saeed","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.addr.2018.06.022_bb0940","doi-asserted-by":"crossref","first-page":"36824","DOI":"10.1074\/jbc.M505560200","article-title":"Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion","volume":"280","author":"Rubi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb0945","first-page":"1161","article-title":"Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET","volume":"45","author":"Becherer","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0950","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/diabetes.55.01.06.db05-1128","article-title":"Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography","volume":"55","author":"Otonkoski","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb0955","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12149-013-0779-4","article-title":"On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass","volume":"28","author":"Eriksson","year":"2014","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0960","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1089\/dia.2014.0041","article-title":"Imaging pancreas in healthy and diabetic rodent model using [18F]fallypride positron emission tomography\/computed tomography","volume":"16","author":"Garcia","year":"2014","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.addr.2018.06.022_bb0965","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1212\/WNL.47.4.1065","article-title":"Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM","volume":"47","author":"Pizzolato","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2018.06.022_bb0970","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/acs.molpharmaceut.5b00518","article-title":"SPECT of transplanted islets of Langerhans by dopamine 2 receptor targeting in a rat model","volume":"13","author":"Willekens","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2018.06.022_bb0975","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/dom.12857","article-title":"Quantitative and longitudinal imaging of intramuscular transplanted islets of Langerhans with SPECT using [ 123 I]IBZM","volume":"19","author":"Willekens","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb0980","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1038\/srep15521","article-title":"Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin","volume":"5","author":"Eter","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.06.022_bb0985","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nm1316","article-title":"In vivo imaging of islet transplantation","volume":"12","author":"Evgenov","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb0990","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/TP.0b013e3181a5cbc0","article-title":"In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates","volume":"87","author":"Medarova","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2018.06.022_bb0995","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.2337\/db06-0393","article-title":"Imaging islets labeled with magnetic nanoparticles at 1.5\u202fTesla","volume":"55","author":"Tai","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb1000","first-page":"35","article-title":"Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application","volume":"1","author":"Wang","year":"2011","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/j.addr.2018.06.022_bb1005","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nbt1154","article-title":"Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy","volume":"23","author":"de Vries","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.06.022_bb1010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nri3531","article-title":"Tracking immune cells in vivo using magnetic resonance imaging","volume":"13","author":"Ahrens","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2018.06.022_bb1015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/dmrr.1248","article-title":"Imaging of pancreatic islet cells","volume":"27","author":"Arifin","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.addr.2018.06.022_bb1020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2214\/ajr.152.1.167","article-title":"Superparamagnetic iron oxide: pharmacokinetics and toxicity","volume":"152","author":"Weissleder","year":"1989","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.addr.2018.06.022_bb1025","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1600-6143.2007.02120.x","article-title":"Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling","volume":"8","author":"Toso","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2018.06.022_bb1030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057046","article-title":"In vivo imaging of transplanted islets labeled with a novel cationic nanoparticle","volume":"8","author":"Oishi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.06.022_bb1035","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.2337\/db06-0484","article-title":"In vivo imaging of immune rejection in transplanted pancreatic islets","volume":"55","author":"Evgenov","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb1040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nprot.2006.63","article-title":"In vivo multimodal imaging of transplanted pancreatic islets","volume":"1","author":"Medarova","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2018.06.022_bb1045","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nm1581","article-title":"Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells","volume":"13","author":"Barnett","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb1050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1148\/radiol.10092339","article-title":"Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging","volume":"258","author":"Barnett","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.addr.2018.06.022_bb1055","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/anie.201007494","article-title":"Multifunctional capsule-in-capsules for immunoprotection and trimodal imaging","volume":"50","author":"Kim","year":"2011","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.addr.2018.06.022_bb1060","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1073\/pnas.1016409108","article-title":"Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets","volume":"108","author":"Lee","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.06.022_bb1065","first-page":"259","article-title":"Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible","volume":"5","author":"Selvaraju","year":"2015","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1070","doi-asserted-by":"crossref","first-page":"R203","DOI":"10.1530\/ERC-17-0005","article-title":"Molecular imaging in the investigation of hypoglycaemic syndromes and their management","volume":"24","author":"Pattison","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.addr.2018.06.022_bb1075","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MPA.0000000000000110","article-title":"A systematic review of localization, surgical treatment options, and outcome of insulinoma","volume":"43","author":"Mehrabi","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.addr.2018.06.022_bb1080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","article-title":"Diagnosis and management of insulinoma","volume":"19","author":"Okabayashi","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.addr.2018.06.022_bb1085","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2006-1479","article-title":"Fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients","volume":"92","author":"Kauhanen","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb1090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/jc.2009-1357","article-title":"Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia","volume":"95","author":"Tessonnier","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb1095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4329\/wjr.v6.i6.252","article-title":"Congenital hyperinsulinism: role of fluorine-18L-3, 4 hydroxyphenylalanine positron emission tomography scanning","volume":"6","author":"Gopal-Kothandapani","year":"2014","journal-title":"World J. Radiol."},{"key":"10.1016\/j.addr.2018.06.022_bb1100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00259-014-2943-z","article-title":"18F-FDOPA PET\/CT imaging of insulinoma revisited","volume":"42","author":"Imperiale","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1105","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2004-1938","article-title":"Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography","volume":"90","author":"Orlefors","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb1110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(13)70049-4","article-title":"Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study","volume":"1","author":"Christ","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.addr.2018.06.022_bb1115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00259-009-1363-y","article-title":"68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET","volume":"37","author":"Brom","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1120","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2003.12.182","article-title":"Systematic screening of potential beta-cell imaging agents","volume":"314","author":"Sweet","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2018.06.022_bb1125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1148\/radiol.2532081445","article-title":"Value of 18F-fluoro-l-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism","volume":"253","author":"Capito","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.addr.2018.06.022_bb1130","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2007-2036","article-title":"Evaluation of [18F]fluoro-l-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism","volume":"93","author":"Barthlen","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb1135","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s00259-007-0498-y","article-title":"The added value of [18F]fluoro-l-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children","volume":"34","author":"Ribeiro","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1140","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/jc.2007-1637","article-title":"Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism","volume":"92","author":"Hardy","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb1145","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2967\/jnumed.113.125187","article-title":"Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas","volume":"55","author":"Eriksson","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb1150","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.2337\/db13-1877","article-title":"Positron emission tomography ligand [11C]5-hydroxy-tryptophan can be used as a surrogate marker for the human endocrine pancreas","volume":"63","author":"Eriksson","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb1155","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.2337\/db16-0222","article-title":"Positron emission tomography to assess the outcome of intraportal islet transplantation","volume":"65","author":"Eriksson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb1160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cancers4010100","article-title":"PET-guided surgery - high correlation between positron emission tomography with 11C-5-hydroxytryptophane (5-HTP) and surgical findings in abdominal neuroendocrine tumours","volume":"4","author":"Orlefors","year":"2012","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.addr.2018.06.022_bb1165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2967\/jnumed.116.180588","article-title":"Effect of carbidopa on 18F-FDOPA uptake in insulinoma: from cell culture to small-animal PET imaging","volume":"58","author":"Detour","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb1170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00259-005-1891-z","article-title":"Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography","volume":"33","author":"Orlefors","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1175","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-012-2330-6","article-title":"The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours","volume":"40","author":"Bodei","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1180","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2967\/jnumed.110.085142","article-title":"Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas","volume":"52","author":"Wild","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb1185","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1021\/jm100602m","article-title":"Development of potent glucagon-like peptide-1 agonists with high enzyme stability via introduction of multiple lactam bridges","volume":"53","author":"Murage","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb1190","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1021\/mp200141x","article-title":"PET of insulinoma using (1)(8)F-FBEM-EM3106B, a new GLP-1 analogue","volume":"8","author":"Gao","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2018.06.022_bb1195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00259-011-1980-0","article-title":"18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma","volume":"39","author":"Kiesewetter","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1200","doi-asserted-by":"crossref","first-page":"999","DOI":"10.7150\/thno.5276","article-title":"Evaluation of an [(18)F]AlF-NOTA analog of exendin-4 for imaging of GLP-1 receptor in insulinoma","volume":"2","author":"Kiesewetter","year":"2012","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2018.06.022_bb1205","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2013-3541","article-title":"Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report","volume":"99","author":"Eriksson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2018.06.022_bb1210","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00259-014-2946-9","article-title":"68Ga-NOTA-exendin-4 PET\/CT in detection of occult insulinoma and evaluation of physiological uptake","volume":"42","author":"Luo","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1215","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2967\/jnumed.115.157768","article-title":"Localization of hidden insulinomas with (6)(8)Ga-DOTA-Exendin-4 PET\/CT: a pilot study","volume":"56","author":"Antwi","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2018.06.022_bb1220","first-page":"111","article-title":"Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use","volume":"7","author":"Velikyan","year":"2017","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1225","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7150\/thno.7759","article-title":"(64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression","volume":"4","author":"Wu","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2018.06.022_bb1230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cmmi.475","article-title":"Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas","volume":"7","author":"Brom","year":"2012","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1235","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s00259-013-2684-4","article-title":"Radiolabelled GLP-1 receptor antagonist binds to GLP-1 receptor-expressing human tissues","volume":"41","author":"Waser","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1240","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.bmc.2016.12.051","article-title":"Development of 111In-labeled exendin(9-39) derivatives for single-photon emission computed tomography imaging of insulinoma","volume":"25","author":"Kimura","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2018.06.022_bb1245","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.nucmedbio.2015.08.001","article-title":"A freeze-dried kit formulation for the preparation of Lys(27)(99mTc-EDDA\/HYNIC)-Exendin(9-39)\/99mTc-EDDA\/HYNIC-Tyr3-Octreotide to detect benign and malignant insulinomas","volume":"42","author":"Medina-Garcia","year":"2015","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.06.022_bb1250","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/MNM.0000000000000736","article-title":"99mTc-exendin(9-39)\/octreotide: biokinetics and radiation dosimetry in healthy individuals","volume":"38","author":"Ocampo-Garcia","year":"2017","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.addr.2018.06.022_bb1255","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4093\/dmj.2016.40.2.118","article-title":"Is an oral glucose tolerance test still valid for diagnosing diabetes mellitus?","volume":"40","author":"Kim","year":"2016","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.addr.2018.06.022_bb1260","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/db10-1591","article-title":"A therapeutic insight in beta-cell imaging?","volume":"60","author":"Gotthardt","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb1265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrgastro.2016.144","article-title":"Imaging in pancreatic disease","volume":"14","author":"Dimastromatteo","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2018.06.022_bb1270","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1158\/1078-0432.CCR-06-2965","article-title":"[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma","volume":"13","author":"Wicki","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2018.06.022_bb1275","article-title":"Synthesis and evaluation of optical and PET GLP-1 peptide analogues for GLP-1R imaging","volume":"14","author":"Behnam Azad","year":"2015","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1280","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fendo.2017.00382","article-title":"In vivo imaging of transplanted pancreatic islets","volume":"8","author":"Kim","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.addr.2018.06.022_bb1285","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2174\/138161210791164117","article-title":"Identification of new pancreatic beta cell targets for in vivo imaging by a systems biology approach","volume":"16","author":"Bouckenooghe","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2018.06.022_bb1290","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.7150\/thno.19679","article-title":"Type 1 diabetes: urinary proteomics and protein network analysis support perturbation of lysosomal function","volume":"7","author":"Singh","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2018.06.022_bb1295","first-page":"310","article-title":"Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis","volume":"6","author":"Ghasemi","year":"2016","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2018.06.022_bb1300","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.jprot.2012.03.008","article-title":"Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates","volume":"75","author":"Lindskog","year":"2012","journal-title":"J. Proteome"},{"key":"10.1016\/j.addr.2018.06.022_bb1305","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00592-015-0811-3","article-title":"GPR44 is a pancreatic protein restricted to the human beta cell","volume":"53","author":"Hellstrom-Lindahl","year":"2016","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.addr.2018.06.022_bb1310","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2337\/db17-0764","article-title":"In vivo visualization of beta-cells by targeting of GPR44","volume":"67","author":"Eriksson","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2018.06.022_bb1315","doi-asserted-by":"crossref","first-page":"39800","DOI":"10.1038\/srep39800","article-title":"Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin","volume":"7","author":"van der Kroon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.06.022_bb1320","series-title":"Noninvasive PET imaging of T cells","author":"Wei","year":"2018"},{"key":"10.1016\/j.addr.2018.06.022_bb1325","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7150\/thno.3677","article-title":"Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications","volume":"2","author":"Yaghoubi","year":"2012","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2018.06.022_bb1330","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1002\/smll.201500735","article-title":"Recent advances in higher-order, multimodal, biomedical imaging agents","volume":"11","author":"Rieffel","year":"2015","journal-title":"Small"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X18301613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X18301613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:45:09Z","timestamp":1759207509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X18301613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":266,"alternative-id":["S0169409X18301613"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2018.06.022","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular imaging of \u03b2-cells: diabetes and beyond","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2018.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}